Nichiban Co., Ltd. (4218.T)
Tokyo, JP
Nichiban Co., Ltd. operates as a manufacturer and distributor of medical supplies and various adhesive tapes across Asian and European markets. Its range of medical offerings encompasses products like surgical and dressing tapes, alongside first-aid and hemostatic bandages. The company also provides over-the-counter (OTC) solutions, which include anti-inflammatory patches, foot care items, waterproof films, and general bandages. For athletic and support needs, Nichiban supplies an assortment of taping products such as cotton, elastic, kinesiology, and strapping tapes. Within its stationery division, the company offers cellulose adhesive tapes, double-sided tapes, adhesive transfer tapes, and book-binding tapes. Furthermore, Nichiban produces industrial tapes tailored for diverse applications, including non-heavy-duty packaging, carton sealing, agricultural use, vehicles, and machinery, in addition to specialized tape solutions. The company's tape portfolio also features cellulose, OPP packing, kraft paper, lithographic, and crepe tapes. Founded in 1918, Nichiban Co., Ltd. maintains its headquarters in Tokyo, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.31% | +2.85% | -0.64% | -4.38% | -4.23% | -6.06% | -3.60% | -1.16% | +10.87% | +36.21% | +203.72% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Business Equipment & Supplies: +4.2%+2.1% Q1'26: +5.3% (vs Q1'25)
-
EPS growth Business Equipment & Supplies: +9.0%-15.7% Q1'26: +34.2% (vs Q1'25)
-
FCF margin FCF growth · Business Equipment & Supplies: +11.3%+1.6% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Business Equipment & Supplies: +8.5%+4.5% Q1'26: +4.0% (vs Q1'25)
-
ROIC Business Equipment & Supplies: +6.9%+5.5% Q1'26: +6.3% (vs Q1'25)
-
Share dilution Business Equipment & Supplies: +0.1%0.0% Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Business Equipment & Supplies: -1.46×0.42× ★ Q1'26: 0.45× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 2 Rev. Ana. 2 EPS Ana. |
Mar 2027 2 Rev. Ana. 2 EPS Ana. |
Mar 2028 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
39.89B
est: 42.70B (-6.6%)
|
46.23B
est: 46.80B (-1.2%)
|
47.42B
est: 47.70B (-0.6%)
|
44.06B
est: 44.50B (-1.0%)
|
41.34B
est: 41.90B (-1.3%)
|
43.13B
est: 42.70B (+1.0%)
|
45.56B
est: 45.90B (-0.7%)
|
46.86B
est: 47.80B (-2.0%)
|
49.46B
est: 49.20B (+0.5%)
|
50.00B
49.83B – 50.17B
+1.6% YoY
|
51.13B
51.00B – 51.25B
+2.3% YoY
|
52.23B
52.00B – 52.45B
+2.2% YoY
|
| EBITDA |
7.70B
est: 5.00B (+54.0%)
|
6.38B
est: 5.48B (+16.3%)
|
6.01B
est: 5.59B (+7.5%)
|
5.33B
est: 5.21B (+2.2%)
|
4.34B
est: 4.91B (-11.5%)
|
5.00B
est: 5.00B (-0.2%)
|
4.37B
est: 5.38B (-18.8%)
|
4.87B
est: 5.13B (-5.1%)
|
5.73B
est: 5.24B (+9.3%)
|
5.33B
5.31B – 5.35B
+1.6% YoY
|
5.45B
5.43B – 5.46B
+2.3% YoY
|
5.56B
5.54B – 5.59B
+2.2% YoY
|
| EBIT |
6.32B
est: 2.45B (+158.3%)
|
4.42B
est: 2.68B (+64.8%)
|
3.68B
est: 2.73B (+34.8%)
|
2.98B
est: 2.55B (+16.7%)
|
2.00B
est: 2.40B (-16.7%)
|
2.45B
est: 2.45B (+0.1%)
|
1.61B
est: 2.63B (-38.8%)
|
2.07B
est: 2.27B (-8.5%)
|
2.59B
est: 2.30B (+12.5%)
|
2.34B
2.33B – 2.34B
+1.6% YoY
|
2.39B
2.38B – 2.40B
+2.2% YoY
|
2.44B
2.43B – 2.45B
+2.2% YoY
|
| Net Income |
1.31B
est: 1.47B (-11.1%)
|
3.13B
est: 3.14B (-0.4%)
|
3.19B
est: 2.93B (+8.9%)
|
1.75B
est: 1.96B (-10.9%)
|
1.35B
est: 1.38B (-1.9%)
|
1.81B
est: 1.77B (+2.2%)
|
2.37B
est: 2.62B (-9.4%)
|
1.83B
est: 1.80B (+1.4%)
|
1.96B
est: 2.10B (-6.7%)
|
1.40B
1.39B – 1.41B
-33.4% YoY
|
1.80B
1.60B – 2.00B
+28.6% YoY
|
1.90B
1.65B – 2.15B
+5.6% YoY
|
| SGA |
3.97B
est: 10.90B (-63.6%)
|
9.63B
est: 11.95B (-19.4%)
|
10.27B
est: 12.18B (-15.7%)
|
10.53B
est: 11.36B (-7.3%)
|
10.12B
est: 10.70B (-5.4%)
|
9.99B
est: 10.90B (-8.4%)
|
10.26B
est: 11.72B (-12.5%)
|
10.60B
est: 10.99B (-3.6%)
|
10.97B
est: 11.39B (-3.7%)
|
11.57B
11.53B – 11.61B
+1.6% YoY
|
11.83B
11.80B – 11.86B
+2.3% YoY
|
12.09B
12.04B – 12.14B
+2.2% YoY
|
| EPS |
63.26
est: 72.40 (-12.6%)
|
151.15
est: 154.40 (-2.1%)
|
154.09
est: 143.96 (+7.0%)
|
84.50
est: 96.50 (-12.4%)
|
65.15
est: 67.60 (-3.6%)
|
87.30
est: 86.90 (+0.5%)
|
114.66
est: 128.55 (-10.8%)
|
88.98
est: 88.45 (+0.6%)
|
96.24
est: 103.20 (-6.7%)
|
68.80
68.50 – 69.10
-33.3% YoY
|
88.40
78.60 – 98.20
+28.5% YoY
|
93.35
81.10 – 105.60
+5.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A- | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-12 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-11 | B+ | 3/5 | 5/5 | 2/5 | 3/5 | 3/5 | 2/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-01 | A- | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 3/5 | 2/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - International Small Cap ETF DFIS | 0.00% | 222.9K | 0.39% |
| 2 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 516.8K | 0.06% |
| 3 | iShares Core TOPIX ETF 1475.T | 0.00% | 324.4K | 0.05% |
| 4 | Vanguard FTSE Developed Asia Pacific All Cap Index ETF VA.TO | 0.00% | 2.5K | 0.22% |
| 5 | Vanguard FTSE Pacific ETF VPL | 0.00% | 141.5K | 0.07% |
| 6 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 140.4K | 0.22% |
| 7 | Avantis International Small Cap Equity ETF AVDS | 0.00% | 2.4K | 0.30% |
| 8 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 72.2K | 0.28% |
| 9 | Vanguard ESG International Stock ETF VSGX | 0.00% | 29.3K | 0.10% |
| 10 | Vanguard FTSE Developed All Cap ex U.S. Index ETF VDU.TO | 0.00% | 2.6K | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hideaki Hara | Managing Executive Officer & Director | — | male |
| Hironori Sakai | Senior MD & Director | — | male |
| Isao Nakamura | Senior Executive Officer & GM of Consumer Sales Division | — | — |
| Kazuhisa Okai | Senior Executive Officer & General Manager of Research and Development Division | — | — |
| Masato Katagiri | Senior Executive Officer | — | — |
| Takemasa Kokubo | Senior Executive Officer & General Manager of Quality Assurance Division | — | male |
| Toshiaki Takatsu | Chief Executive Officer, President & Representative Director | — | male |
| Yasuhiko Takahashi | Managing Exe Officer, Corporate Planning Office Manager & Director | — | male |
| Yuko Kobayashi | Executive Officer & Head of Corporate Communications Department | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4218.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
